Efgartigimod demonstrates consistent improvements in patients with generalized myasthenia gravis regardless of prior treatment failures Siddiqi, Z., Rozsa, C., Sacca, F., De Bleecker, J. L., Verschuuren, J., Hoffmann, S., Vu, T., Bril, V., Murai, H., Brauer, E., Kerstens, R., Steeland, S., Ulrichts, P., Goyal, N., Vissing, J., Mantegazza, R., Howard, J. F. ELSEVIER. 2023

View details for DOI 10.1016/j.jns.2023.121094

View details for Web of Science ID 001163199100224